baccaratchristmas|翰宇药业：利拉鲁肽制剂及多种GLP-1原料药签约订单金额合计近6亿元

News summary

Hanyu pharmaceuticalbaccaratchristmas: The total signed order amount for liraglutide preparations and various GLP-1 APIs is nearly 600 million yuan. Securities Times e Company Newsbaccaratchristmas, Hanyu Pharmaceutical said on the interactive platform today that as of today, the company's signed orders for liraglutide preparations and various GLP-1 APIs totaled nearly 600 million yuan, and somebaccaratchristmas.baccaratchristmas..

Newsletter text

Hanyu Pharmaceutical: The total contracted order value of liraglutide preparations and various GLP-1 raw materials is nearly 600 million yuan. According to Securities Times e Company, Hanyu Pharmaceutical said on the interactive platform today that as of today, the company's liraglutide preparations and various GLP-1 raw materials have signed orders totaling nearly 600 million yuan, and some orders have been shipped one after another; the preparation production base has obtained EU GMP certification and U.S. cGMP certification, and the API production base has passed Australia TGA-GMP certification and U.S. cGMP certification.

Tags:

Prev: playpokeragainstcomputer|医药生物行业周报：板块逐渐企稳 积极布局新机遇
Next: crazytaxiarcade|汇丰将美联储年内降息幅度的预期从75个基点下调至25个基点